Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin

Lorraine M Deck1, Lucy A Hunsaker2, Thomas A Vander Jagt2

  • 1Department of Chemistry and Chemical Biology, University of New Mexico, MSC03 2060, 1 University of New Mexico, Albuquerque, NM 87131, USA.

Insights

New curcumin analogues activate the Nrf2 pathway, offering potential for treating chronic diseases linked to inflammation and oxidative stress. These compounds show enhanced Nrf2 activation compared to curcumin.

Area of Science:

  • Biochemistry and Molecular Biology
  • Neuroscience
  • Pharmacology

Background:

  • Inflammation and oxidative stress are hallmarks of chronic diseases, necessitating therapeutic strategies targeting key signaling pathways.
  • The transcription factor Nrf2 (Nuclear factor erythroid 2-related factor 2) is a critical regulator of antioxidant, anti-inflammatory, and neuroprotective genes, particularly in the central nervous system (CNS).
  • Curcumin, a natural product, activates Nrf2 but suffers from poor bioavailability and rapid metabolism, limiting its clinical efficacy.

Purpose of the Study:

  • To synthesize and evaluate novel enone analogues of curcumin for their ability to activate the Nrf2 pathway.
  • To identify structural features that enhance Nrf2 activation and overcome curcumin's pharmacokinetic limitations.

Main Methods:

  • Curcumin analogues with varying enone spacer lengths (3, 5, or 7 carbons) and aromatic ring substitutions were synthesized.
  • An Nrf2 reporter assay was employed to screen and quantify the activation potential of these analogues.
  • Dose-response studies were conducted to determine EC50 values and the extent of Nrf2 activation.

Main Results:

  • Nrf2 activators were identified across all synthesized analogue groups, with many exhibiting greater potency than curcumin.
  • The length of the enone spacer and substituents on the aromatic rings significantly influenced both the sensitivity (EC50) and efficacy of Nrf2 activation.
  • These findings suggest diverse mechanisms underlying Nrf2 activation by the enone analogues.

Conclusions:

  • Novel curcumin enone analogues represent a promising class of compounds for activating the Nrf2 pathway.
  • Structural modifications can significantly enhance Nrf2 activation, potentially leading to more effective therapeutics for Nrf2-mediated conditions.
  • Further investigation into these analogues may yield new treatments for chronic inflammatory and oxidative stress-related diseases.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.4K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
16
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.6K